CD4+ decline (slope) Throughout study [clinicaltrials_resource:bbf8f215603509eb2efc1d652c325605]

CD4+ decline (slope) Throughout study [clinicaltrials_resource:bbf8f215603509eb2efc1d652c325605]

Participants will receive 6 months of ARV therapy and treatment for TB
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:bbf8f215603509eb2efc1d652c325605
Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis [clinicaltrials:NCT00078247]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

CD4+ decline (slope) Throughout study [clinicaltrials_resource:bbf8f215603509eb2efc1d652c325605]

Participants will receive 6 months of ARV therapy and treatment for TB
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:bbf8f215603509eb2efc1d652c325605
Bio2RDF identifier
bbf8f215603509eb2efc1d652c325605
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:bbf8f215603509eb2efc1d652c325605
measure [clinicaltrials_vocabulary:measure]
time frame [clinicaltrials_vocabulary:time-frame]
description
Participants will receive 6 months of ARV therapy and treatment for TB
identifier
clinicaltrials_resource:bbf8f215603509eb2efc1d652c325605
title
CD4+ decline (slope) Throughout study
@en
inDataset
type
label
CD4+ decline (slope) Throughou ...... 8f215603509eb2efc1d652c325605]
@en